Paper Details

  1. Home
  2. Paper Details

[Moexipril and cardiovascular diseases in women: is there a reason for optimism?].

Author:

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study discusses the use of angiotensin converting enzyme (ACE) inhibitors in the treatment of chronic heart failure. It highlights the evidence that ACE inhibitors may exert less pronounced favorable prognostic influence in women compared with men. The study suggests that further research on the efficacy of moexipril in chronic heart failure in women may broaden the indications for its use.
Paper Details　
Original Abstract of the Article :
Angiotensin converting enzyme (ACE) inhibitors are first line preparations in the treatment of chronic heart failure irrespective of etiology. However there are numerous proofs that in women drugs of this group exert less pronounced favorable prognostic influence compared with men. Moexipril is an A...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/16883271

データ提供：米国国立医学図書館（NLM）

Moexipril: A Potential Solution for Cardiovascular Disease in Women

Cardiovascular disease is a major health concern, particularly for women. This research explores the use of moexipril, an angiotensin-converting enzyme (ACE) inhibitor, as a treatment for cardiovascular disease in women. The authors examine the effectiveness of moexipril in managing hypertension and its potential benefits for women with cardiovascular disease.

The authors suggest that moexipril, unlike other ACE inhibitors, has shown promising results in women with cardiovascular disease. It has been effective in lowering blood pressure and may offer additional benefits. This is a reminder that, just as a camel adapts to different desert environments, finding the right treatment for women with cardiovascular disease requires a tailored approach.

Moexipril: A Personalized Approach for Women's Health

This research highlights the need for a personalized approach to cardiovascular disease in women. Moexipril, with its potential benefits, offers hope for women seeking effective treatment options. This is a step towards a more inclusive and tailored approach to women's cardiovascular health.

A Journey Towards Health: Finding the Right Path for Women

This research emphasizes the importance of finding the right treatment for women with cardiovascular disease. Moexipril shows promise as a potential solution, offering a more personalized and effective approach to managing this complex health condition. It's a reminder that the journey towards better health is often unique and requires a search for the right path for each individual.

Dr. Camel's Conclusion

This research explores the use of moexipril for cardiovascular disease in women. It suggests that moexipril may offer a more personalized and effective approach to managing this complex health condition. This is a journey towards a healthier future for women, guided by the pursuit of better treatment options and a deeper understanding of women's unique health needs.

Date :
  1. Date Completed 2006-10-05
  2. Date Revised 2017-03-10
Further Info :

Pubmed ID

16883271

DOI: Digital Object Identifier

16883271

Related Literature

Article Analysis
・Effects of moexipril
SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.